lomustine has been researched along with Nausea in 15 studies
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
Excerpt | Relevance | Reference |
---|---|---|
"Thirty-seven consecutive patients with disseminated malignant melanoma and previously untreated with chemotherapy were randomly allocated to receive vindesine, cis-platinum, and etoposide (Regimen A) or vindesine, cis-platinum, and lomustine (Regimen B)." | 9.05 | Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine. ( Bajetta, E; Bonadonna, G; Buzzoni, R; Nava, M; Vaglini, M; Viviani, S, 1985) |
"One hundred and six patients with advanced adenocarcinoma and large cell carcinoma of the lung with no prior chemotherapy were entered in a prospectively randomized trial comparing cyclophosphamide, doxorubicin, and cisplatin versus methotrexate, doxorubicin, cyclophosphamide, and lomustine." | 5.05 | Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study. ( Cullinan, S; Eagan, RT; Elliott, T; Etzell, P; Fleming, TR; Krook, JE; Pfeifle, D, 1984) |
"Thirty-seven consecutive patients with disseminated malignant melanoma and previously untreated with chemotherapy were randomly allocated to receive vindesine, cis-platinum, and etoposide (Regimen A) or vindesine, cis-platinum, and lomustine (Regimen B)." | 5.05 | Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine. ( Bajetta, E; Bonadonna, G; Buzzoni, R; Nava, M; Vaglini, M; Viviani, S, 1985) |
"Forty-three patients with inoperable or recurring malignant gliomas, and 30 patients with multiple recurring brain metastases were treated with a combination of Adriamycin (45 mg/m2) and 4-dimethyl-epipodophyllotoxin D-thenylidene (VM 26) (60 mg/m2 for 2 days) with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (60 mg/m2 for 2 days)." | 3.65 | Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail. ( Gauthier, H; Huguenin, P; Lheritier, J; Mathe, G; Morin, P; Parrot, R; Poisson, M; Pouillart, P; Thy, TH, 1976) |
"Lomustine is a commercially available chloroethyl nitrosourea compound whose antitumor activity in vitro and in animal tumor models exceeds its activity in humans." | 2.67 | A phase I trial of weekly lomustine in patients with advanced cancer. ( Benjamin, RS; Gorski, CC; Koller, CA; Legha, SS; Papadopoulos, NE; Plager, C, 1994) |
"Thirty-five patients with advanced breast cancer refractory to initial chemotherapy were randomized to receive two-drug doxorubicin-CCNU or three-drug doxorubicin-CCNU-vincristine (VCR) treatment." | 2.65 | Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trial. ( Bateman, JR; Block, JB; Chlebowski, RT; Pugh, R; Weiner, JM, 1983) |
" The dosage of CCNU was 100 mg/m2 p." | 2.65 | The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study. ( Brunner, K; Cuttner, J; Falkson, G; Hansen, HH; Holland, JF; Nissen, NI; Pajak, TF; Selawry, OS; Spurr, CL, 1981) |
"It is an effective drug in the treatment of malignant melanoma with better response rates in women than in men." | 2.64 | Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group. ( Hill, G; Johnson, RO; Krementz, E; Metter, G; Wilson, W, 1976) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (93.33) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diggs, CH | 1 |
Wiernik, PH | 1 |
Sutherland, JC | 1 |
Krook, JE | 1 |
Fleming, TR | 1 |
Eagan, RT | 1 |
Cullinan, S | 1 |
Pfeifle, D | 1 |
Elliott, T | 1 |
Etzell, P | 1 |
Chlebowski, RT | 2 |
Pugh, R | 1 |
Weiner, JM | 1 |
Block, JB | 2 |
Bateman, JR | 2 |
Whitehead, RP | 1 |
Rosenbaum, PR | 1 |
Carbone, PP | 1 |
Hansen, HH | 1 |
Selawry, OS | 1 |
Pajak, TF | 2 |
Spurr, CL | 1 |
Falkson, G | 1 |
Brunner, K | 1 |
Cuttner, J | 1 |
Nissen, NI | 1 |
Holland, JF | 1 |
Gagliano, RG | 1 |
Panettiere, FJ | 1 |
Haas, CD | 1 |
Baker, L | 1 |
Hewlett, J | 1 |
Stuckey, WJ | 1 |
O'Bryan, RM | 1 |
Bottomley, R | 1 |
Heilburn, LK | 1 |
Koller, CA | 1 |
Gorski, CC | 1 |
Benjamin, RS | 1 |
Legha, SS | 1 |
Papadopoulos, NE | 1 |
Plager, C | 1 |
Reagan, TJ | 1 |
Bisel, HF | 1 |
Childs, DS | 1 |
Layton, DD | 1 |
Rhoton, AL | 1 |
Taylor, WF | 1 |
Stolinsky, DC | 1 |
Bull, FE | 1 |
Johnson, RO | 1 |
Metter, G | 1 |
Wilson, W | 1 |
Hill, G | 1 |
Krementz, E | 1 |
Wasserman, TH | 1 |
Pouillart, P | 1 |
Mathe, G | 1 |
Thy, TH | 1 |
Lheritier, J | 1 |
Poisson, M | 1 |
Huguenin, P | 1 |
Gauthier, H | 1 |
Morin, P | 1 |
Parrot, R | 1 |
Page, JP | 1 |
Levi, JA | 1 |
Woods, RL | 1 |
Tattersall, MN | 1 |
Fox, RM | 1 |
Coates, AS | 1 |
Bajetta, E | 1 |
Buzzoni, R | 1 |
Viviani, S | 1 |
Vaglini, M | 1 |
Nava, M | 1 |
Bonadonna, G | 1 |
Chlebowski, JS | 1 |
Herrold, J | 1 |
Richardson, B | 1 |
Ali, I | 1 |
Oktay, E | 1 |
10 trials available for lomustine and Nausea
Article | Year |
---|---|
Treatment of advanced untreated Hodgkin's disease with SCAB--an alternative to MOPP.
Topics: Adult; Bleomycin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodg | 1981 |
Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1984 |
Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trial.
Topics: Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Humans; | 1983 |
The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study.
Topics: Adult; Carmustine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration S | 1981 |
A phase I trial of weekly lomustine in patients with advanced cancer.
Topics: Administration, Oral; Adult; Aged; Capsules; Carcinoma, Renal Cell; Drug Administration Schedule; Dr | 1994 |
Controlled study of CCNU and radiation therapy in malignant astrocytoma.
Topics: Adult; Aged; Brain Neoplasms; Digestive System; Drug Evaluation; Glioblastoma; Hematopoiesis; Humans | 1976 |
Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.
Topics: Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Femal | 1976 |
Randomized trial of combination chemotherapy in hormone-resistant metastatic prostate carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Do | 1985 |
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic | 1985 |
Doxorubicin, cyclophosphamide, CCNU, and vincristine with or without cisplatinum in non-small cell lung cancer.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma; Cisplati | 1985 |
5 other studies available for lomustine and Nausea
Article | Year |
---|---|
Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Cisplatin; Cyclophosp | 1984 |
Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. A Southwest Oncology Group study.
Topics: Adenocarcinoma; Colonic Neoplasms; Deoxyguanosine; Drug Evaluation; Drug Therapy, Combination; Human | 1981 |
Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Carcinoma, Bronchogenic; Carcinoma, Small Cell; | 1975 |
The nitrosoureas: an outline of clinical schedules and toxic effects.
Topics: Administration, Oral; Bone Marrow; Capsules; Carmustine; Humans; Injections, Intravenous; Lomustine; | 1976 |
Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail.
Topics: Adult; Aged; Brain Neoplasms; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; Glioma | 1976 |